申请人:CIBA-GEIGY AG
公开号:EP0107618A1
公开(公告)日:1984-05-02
The invention concerns compounds with thromboxane synthetase inhibitor properties of the formula I
wherein Ri represents hydrogen or lower alkyl; lm represents 1-imidazolyl unsubstituted or substituted by lower alkyl, carboxy, lower alkoxycarbonyl or carbamoyl; R2 and R3 independently represent hydrogen, lower alkyl, halogen, trifluoromethyl, hydroxy, lower alkoxy, lower alkyl-(thio, sulfinyl or sulfonyl), or R2 and R3 together when attached to adjacent carbons represent lower alkylenedroxy; A represents alkylene of 1 to 12 carbon atoms, alkenylene of 2 to 12 carbon atoms, alkynylene of 2 to 12 carbon atoms, lower alkylenephenylene-lower al- kylene, lower alkylenephenylene, phenylene-lower alkylene, phenylene, a direct bond, lower alkylene-(thio or oxy)-lower alkylene, (thio- or oxy)-phenylene, lower alkylene-(thio- or oxy)-p) enylene, Phenylene-(thio or oxy)-lower alkylene or phenyl one lower alkenylene: B represents carboxy. lower alkoxycarbonyl, carbamoyl, mono- or di-lower alkylcarbamoyl, cyano, hydroxymethyl, hydroxycarbamoyl, 5-tetrazolyl or formyl; the N-oxides thereof; and salts thereof.
They are prepared, for example, by condensing a compound corresponding to the formula I, in which the nitrogen atom carries only a hydrogen atom, with a reactive functional derivative of a compound of the formula HOCH2-A-B.
本发明涉及具有血栓素合成酶抑制剂特性的式 I 化合物
其中Ri代表氢或低级烷基;lm代表未取代的或被低级烷基、羧基、低级烷氧基羰基或氨基甲酰基取代的1-咪唑基;R2和R3独立地代表氢、低级烷基、卤素、三氟甲基、羟基、低级烷氧基、低级烷基-(硫基、亚磺酰基或磺酰基),或R2和R3一起连接到相邻碳时代表低级烷基二氧基;A 代表 1 至 12 个碳原子的亚烷基、2 至 12 个碳原子的亚烯基、2 至 12 个碳原子 的亚炔基、低级亚烷基亚苯基、低级亚烷基亚苯基、亚苯基-低级亚烷基、苯基、直接键、低亚烷基-(硫代或氧基)-低亚烷基、(硫代或氧基)-亚苯基、低亚烷基-(硫代或氧基)-亚 苯基、苯基-(硫代或氧基)-低亚烷基或苯基一低烯基:B 代表羧基。它们包括:低级烷氧基羰基、氨基甲酰基、单或双低级烷基氨基甲酰基、氰基、羟甲基、羟基氨基甲酰基、5-四唑基或甲酰基;它们的 N-氧化物;以及它们的盐。
例如,通过将氮原子只带一个氢原子的式 I 所对应的化合物与式 HOCH2-A-B 所对应的化合物的活性官能团衍生物缩合,就可以制备这些化合物。